| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome.
|
N Engl J Med
|
2007
|
7.31
|
|
2
|
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.
|
CA Cancer J Clin
|
2012
|
5.58
|
|
3
|
The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years.
|
J Infect Dis
|
2009
|
5.09
|
|
4
|
Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.
|
J Natl Cancer Inst
|
2010
|
4.20
|
|
5
|
The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years.
|
J Infect Dis
|
2009
|
3.55
|
|
6
|
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.
|
Am J Clin Pathol
|
2012
|
3.51
|
|
7
|
Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial.
|
BMJ
|
2010
|
3.41
|
|
8
|
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.
|
J Low Genit Tract Dis
|
2012
|
3.15
|
|
9
|
Forecasting the prevalence of pelvic floor disorders in U.S. Women: 2010 to 2050.
|
Obstet Gynecol
|
2009
|
3.08
|
|
10
|
Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality.
|
Am J Obstet Gynecol
|
2006
|
3.08
|
|
11
|
Histological dating of timed endometrial biopsy tissue is not related to fertility status.
|
Fertil Steril
|
2004
|
3.03
|
|
12
|
Risk of cervical cancer associated with extending the interval between cervical-cancer screenings.
|
N Engl J Med
|
2003
|
2.72
|
|
13
|
The health and economic burden of genital warts in a set of private health plans in the United States.
|
Clin Infect Dis
|
2003
|
2.72
|
|
14
|
Absence of secretory endometrium after false-positive home urine luteinizing hormone testing.
|
Fertil Steril
|
2004
|
2.59
|
|
15
|
Incidence and risk factors for stroke in pregnancy and the puerperium.
|
Obstet Gynecol
|
2005
|
2.50
|
|
16
|
Acute myocardial infarction in pregnancy: a United States population-based study.
|
Circulation
|
2006
|
2.49
|
|
17
|
A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital lesions.
|
Cancer Prev Res (Phila)
|
2009
|
2.42
|
|
18
|
Predicting the number of women who will undergo incontinence and prolapse surgery, 2010 to 2050.
|
Am J Obstet Gynecol
|
2011
|
2.36
|
|
19
|
Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
2.18
|
|
20
|
Oral contraceptive pills as primary prevention for ovarian cancer: a systematic review and meta-analysis.
|
Obstet Gynecol
|
2013
|
2.17
|
|
21
|
HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine.
|
Vaccine
|
2008
|
2.09
|
|
22
|
Predictors of pregnancy in women with polycystic ovary syndrome.
|
J Clin Endocrinol Metab
|
2009
|
1.90
|
|
23
|
Potential health and economic impact of adding a human papillomavirus vaccine to screening programs.
|
JAMA
|
2003
|
1.89
|
|
24
|
Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection.
|
Hum Vaccin
|
2009
|
1.66
|
|
25
|
Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS).
|
J Natl Cancer Inst
|
2006
|
1.58
|
|
26
|
Risk of acute thromboembolic events with oral contraceptive use: a systematic review and meta-analysis.
|
Obstet Gynecol
|
2013
|
1.56
|
|
27
|
The Pregnancy in Polycystic Ovary Syndrome study: baseline characteristics of the randomized cohort including racial effects.
|
Fertil Steril
|
2006
|
1.56
|
|
28
|
Development of an ovarian cancer screening decision model that incorporates disease heterogeneity: implications for potential mortality reduction.
|
Cancer
|
2010
|
1.53
|
|
29
|
FDG-PET for management of cervical and ovarian cancer.
|
Gynecol Oncol
|
2005
|
1.52
|
|
30
|
Uterine artery embolization for treatment of leiomyomata: long-term outcomes from the FIBROID Registry.
|
Obstet Gynecol
|
2008
|
1.49
|
|
31
|
Nicotine replacement and behavioral therapy for smoking cessation in pregnancy.
|
Am J Prev Med
|
2007
|
1.44
|
|
32
|
Cost comparison of strategies for the management of venous thromboembolic event risk following laparotomy for ovarian cancer.
|
Gynecol Oncol
|
2011
|
1.44
|
|
33
|
HPV vaccines: now that they're here, how do we maximize their benefit?
|
Contraception
|
2006
|
1.41
|
|
34
|
Cost comparison among robotic, laparoscopic, and open hysterectomy for endometrial cancer.
|
Obstet Gynecol
|
2010
|
1.31
|
|
35
|
Fertility patients' views about frozen embryo disposition: results of a multi-institutional U.S. survey.
|
Fertil Steril
|
2008
|
1.30
|
|
36
|
Total testosterone assays in women with polycystic ovary syndrome: precision and correlation with hirsutism.
|
J Clin Endocrinol Metab
|
2010
|
1.29
|
|
37
|
Effect of hysterectomy with ovarian preservation on ovarian function.
|
Obstet Gynecol
|
2011
|
1.28
|
|
38
|
Abnormal outcomes following cervical cancer screening: event duration and health utility loss.
|
Med Decis Making
|
2007
|
1.28
|
|
39
|
The FIBROID Registry: symptom and quality-of-life status 1 year after therapy.
|
Obstet Gynecol
|
2005
|
1.22
|
|
40
|
Adherence to nicotine replacement therapy among pregnant smokers.
|
Nicotine Tob Res
|
2009
|
1.21
|
|
41
|
Ovulatory response to treatment of polycystic ovary syndrome is associated with a polymorphism in the STK11 gene.
|
J Clin Endocrinol Metab
|
2007
|
1.14
|
|
42
|
Adding a quadrivalent human papillomavirus vaccine to the UK cervical cancer screening programme: A cost-effectiveness analysis.
|
Cost Eff Resour Alloc
|
2008
|
1.14
|
|
43
|
Determination of quality of life-related utilities for health states relevant to ovarian cancer diagnosis and treatment.
|
Gynecol Oncol
|
2009
|
1.12
|
|
44
|
Cost-effectiveness of sacral neuromodulation versus intravesical botulinum A toxin for treatment of refractory urge incontinence.
|
J Urol
|
2009
|
1.10
|
|
45
|
Cost-effectiveness of extending cervical cancer screening intervals among women with prior normal pap tests.
|
Obstet Gynecol
|
2006
|
1.09
|
|
46
|
Reducing ovarian cancer mortality through screening: Is it possible, and can we afford it?
|
Gynecol Oncol
|
2008
|
1.09
|
|
47
|
Management of adnexal mass.
|
Evid Rep Technol Assess (Full Rep)
|
2006
|
1.08
|
|
48
|
Cost-effectiveness of botulinum toxin a versus anticholinergic medications for idiopathic urge incontinence.
|
J Urol
|
2009
|
1.06
|
|
49
|
Challenges and solutions for recruiting pregnant smokers into a nicotine replacement therapy trial.
|
Nicotine Tob Res
|
2006
|
1.01
|
|
50
|
Leiomyoma-related hospitalization and surgery: prevalence and predicted growth based on population trends.
|
Am J Obstet Gynecol
|
2011
|
1.00
|
|
51
|
Accuracy and cost-effectiveness of cervical cancer screening by high-risk human papillomavirus DNA testing of self-collected vaginal samples.
|
J Low Genit Tract Dis
|
2010
|
0.99
|
|
52
|
Projecting the need for gynecologic oncologists for the next 40 years.
|
Obstet Gynecol
|
2010
|
0.99
|
|
53
|
Should older women have antepartum testing to prevent unexplained stillbirth?
|
Obstet Gynecol
|
2004
|
0.97
|
|
54
|
Cost-effectiveness analysis of annual screening strategies for endometrial cancer.
|
Am J Obstet Gynecol
|
2009
|
0.96
|
|
55
|
Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis.
|
J Clin Oncol
|
2013
|
0.94
|
|
56
|
Primary surgery versus chemoradiation in the treatment of IB2 cervical carcinoma: a cost effectiveness analysis.
|
Gynecol Oncol
|
2007
|
0.94
|
|
57
|
Effects of race and clinical factors on short-term outcomes of abdominal myomectomy.
|
Obstet Gynecol
|
2003
|
0.93
|
|
58
|
Screening for cervical cancer: a modeling study for the US Preventive Services Task Force.
|
J Low Genit Tract Dis
|
2013
|
0.93
|
|
59
|
Utility scores and treatment preferences for clinical early-stage cervical cancer.
|
Value Health
|
2011
|
0.93
|
|
60
|
The Fibroid Registry for outcomes data (FIBROID) for uterine embolization: short-term outcomes.
|
Obstet Gynecol
|
2005
|
0.93
|
|
61
|
Smoking prevalence in early pregnancy: comparison of self-report and anonymous urine cotinine testing.
|
J Matern Fetal Neonatal Med
|
2010
|
0.91
|
|
62
|
High throughput, cell type-specific analysis of key proteins in human endometrial biopsies of women from fertile and infertile couples.
|
Hum Reprod
|
2012
|
0.91
|
|
63
|
Cost-effectiveness analysis of liquid-based cytology and human papillomavirus testing in cervical cancer screening.
|
Obstet Gynecol
|
2006
|
0.91
|
|
64
|
Clinical trial experience with prophylactic human papillomavirus 6/11/16/18 vaccine in young black women.
|
J Adolesc Health
|
2012
|
0.91
|
|
65
|
Costs and effectiveness of alternative strategies for cervical cancer screening in military beneficiaries.
|
Obstet Gynecol
|
2002
|
0.89
|
|
66
|
Impact of a routine, opt-out HIV testing program on HIV testing and case detection in North Carolina sexually transmitted disease clinics.
|
Sex Transm Dis
|
2014
|
0.89
|
|
67
|
Cost-effectiveness of BRCA1 and BRCA2 mutation testing to target PARP inhibitor use in platinum-sensitive recurrent ovarian cancer.
|
Int J Gynecol Cancer
|
2013
|
0.88
|
|
68
|
Prioritization of patient-centered comparative effectiveness research for osteoarthritis.
|
Ann Intern Med
|
2014
|
0.88
|
|
69
|
Genomic tests for ovarian cancer detection and management.
|
Evid Rep Technol Assess (Full Rep)
|
2006
|
0.88
|
|
70
|
Adverse birth outcomes among nulliparous vs. multiparous women.
|
Public Health Rep
|
2011
|
0.87
|
|
71
|
Cost-effectiveness of combination versus sequential docetaxel and carboplatin for the treatment of platinum-sensitive, recurrent ovarian cancer.
|
Cancer
|
2011
|
0.87
|
|
72
|
Optimal timing of implantable cardioverter-defibrillator implantation after myocardial infarction: a decision analysis.
|
J Cardiovasc Electrophysiol
|
2010
|
0.86
|
|
73
|
Impact of a chemoresponse assay on treatment costs for recurrent ovarian cancer.
|
Am J Obstet Gynecol
|
2010
|
0.85
|
|
74
|
A prospective study of weight gain after premenopausal hysterectomy.
|
J Womens Health (Larchmt)
|
2009
|
0.84
|
|
75
|
Reductions in human papillomavirus-disease resource use and costs with quadrivalent human papillomavirus (types 6, 11, 16, and 18) recombinant vaccination: the FUTURE Study Economic Evaluation.
|
Value Health
|
2008
|
0.84
|
|
76
|
Comparison of characteristics of fibroids in African American and white women undergoing premenopausal hysterectomy.
|
Fertil Steril
|
2012
|
0.83
|
|
77
|
Cost effectiveness of alternative strategies for incorporating bevacizumab into the primary treatment of ovarian cancer.
|
Cancer
|
2013
|
0.83
|
|
78
|
Predictors of adverse events among pregnant smokers exposed in a nicotine replacement therapy trial.
|
Am J Obstet Gynecol
|
2009
|
0.82
|
|
79
|
Testing for von Willebrand disease in women with menorrhagia: a systematic review.
|
Obstet Gynecol
|
2004
|
0.82
|
|
80
|
Reported symptoms before and one year after hysterectomy in African American and white women.
|
J Womens Health (Larchmt)
|
2011
|
0.82
|
|
81
|
Extended-release metformin does not reduce the clomiphene citrate dose required to induce ovulation in polycystic ovary syndrome.
|
J Clin Endocrinol Metab
|
2008
|
0.81
|
|
82
|
Human papillomavirus testing with Pap triage for cervical cancer prevention in Canada: a cost-effectiveness analysis.
|
BMC Med
|
2009
|
0.81
|
|
83
|
The economic impact of HPV vaccines: not just cervical cancer.
|
Am J Obstet Gynecol
|
2008
|
0.81
|
|
84
|
Oral contraceptive use for the primary prevention of ovarian cancer.
|
Evid Rep Technol Assess (Full Rep)
|
2013
|
0.80
|
|
85
|
Intercourse compliance, ovulation, and treatment success in the National Institute of Child Health and Human Development-Reproductive Medicine Network's Pregnancy in Polycystic Ovary Syndrome (PPCOS) Trial.
|
Fertil Steril
|
2009
|
0.80
|
|
86
|
Prioritization of research addressing management strategies for ductal carcinoma in situ.
|
Ann Intern Med
|
2014
|
0.80
|
|
87
|
How much is another randomized trial of lymph node dissection in endometrial cancer worth? A value of information analysis.
|
Gynecol Oncol
|
2013
|
0.80
|
|
88
|
Body mass index and intercourse compliance.
|
Fertil Steril
|
2009
|
0.80
|
|
89
|
Early physician experience with laparoscopically assisted vaginal hysterectomy and rates of surgical complications and conversion to laparotomy.
|
Am J Obstet Gynecol
|
2002
|
0.79
|
|
90
|
Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treatment of ischemic heart disease: Future research needs prioritization.
|
Am Heart J
|
2012
|
0.79
|
|
91
|
Screening for bacterial vaginosis to prevent preterm birth: assessing effectiveness and cost-effectiveness.
|
Acta Obstet Gynecol Scand
|
2004
|
0.79
|
|
92
|
Utility of screening for other causes of infertility in women with "known" polycystic ovary syndrome.
|
Fertil Steril
|
2006
|
0.79
|
|
93
|
Effectiveness of assisted reproductive technology (ART).
|
Evid Rep Technol Assess (Full Rep)
|
2008
|
0.78
|
|
94
|
Vaginal native tissue repair versus transvaginal mesh repair for apical prolapse: how utilizing different methods of analysis affects the estimated trade-off between reoperation for mesh exposure/erosion and reoperation for recurrent prolapse.
|
Int Urogynecol J
|
2015
|
0.78
|
|
95
|
Development of a research agenda for uterine artery embolization: proceedings from a multidisciplinary research consensus panel.
|
J Vasc Interv Radiol
|
2006
|
0.77
|
|
96
|
How Obamacare will impact reproductive health.
|
Semin Reprod Med
|
2013
|
0.77
|
|
97
|
Cost-Effectiveness of High-Risk Human Papillomavirus Testing With Messenger RNA Versus DNA Under United States Guidelines for Cervical Cancer Screening.
|
J Low Genit Tract Dis
|
2015
|
0.77
|
|
98
|
Preoperative screening strategies for bacterial vaginosis prior to elective hysterectomy: a cost comparison study.
|
Am J Obstet Gynecol
|
2011
|
0.76
|
|
99
|
Decision science and cervical cancer.
|
Cancer
|
2003
|
0.76
|
|
100
|
Is Burch colposuspension ever cost-effective compared with tension-free vaginal tape for stress incontinence?
|
Am J Obstet Gynecol
|
2007
|
0.76
|
|
101
|
Medication adherence and treatment success in the National Institute of Child Health and Human Development-Reproductive Medicine Network's Pregnancy in Polycystic Ovary Syndrome Trial.
|
Fertil Steril
|
2007
|
0.76
|
|
102
|
Metformin and/or clomiphene do not adversely affect liver or renal function in women with polycystic ovary syndrome.
|
J Clin Endocrinol Metab
|
2011
|
0.76
|
|
103
|
Computer modeling informs study design: vaginal estrogen to prevent mesh erosion after different routes of prolapse surgery.
|
Int Urogynecol J
|
2012
|
0.75
|
|
104
|
Association Between Patient Characteristics and Treatment Procedure Among Patients With Uterine Leiomyomas.
|
Obstet Gynecol
|
2016
|
0.75
|
|
105
|
In reply.
|
Obstet Gynecol
|
2013
|
0.75
|
|
106
|
Altering hirsutism through ovulation induction in women with polycystic ovary syndrome.
|
Obstet Gynecol
|
2012
|
0.75
|
|
107
|
Oral contraceptive use and risk of cancer--response.
|
Cancer Epidemiol Biomarkers Prev
|
2014
|
0.75
|
|
108
|
Uterine artery embolization: what more do we need to know?
|
Obstet Gynecol
|
2002
|
0.75
|
|
109
|
Preference-based utility scores for adverse events associated with the treatment of gynecologic cancers.
|
Int J Gynecol Cancer
|
2013
|
0.75
|
|
110
|
Cost effectiveness of a test to detect metastases for endometrial cancer.
|
Gynecol Oncol
|
2008
|
0.75
|
|
111
|
Prioritization of research addressing antipsychotics for adolescents and young adults with bipolar disorder.
|
Ann Intern Med
|
2014
|
0.75
|
|
112
|
Perinatal implications of motor vehicle accident trauma during pregnancy: identifying populations at risk.
|
Am J Obstet Gynecol
|
2013
|
0.75
|
|
113
|
Levonorgestrel Intrauterine Device as an Endometrial Cancer Prevention Strategy in Obese Women: A Cost-Effectiveness Analysis.
|
Obstet Gynecol
|
2016
|
0.75
|